The Eagles and Jalen Hurts’s agent reported an updated diagnosis on Oct. 19: deep vein thrombosis and bilateral pulmonary emboli. Their statement described the quarterback as clinically stable, with no significant functional limitations, and said he would not take part in contact activities during treatment.

The update follows a roster move from Saturday. Philadelphia placed Hurts on injured reserve because of a superficial blood clot in his calf. The team said the move would keep him out for at least four games. NFL.com’s Oct. 19 report says further testing led to the updated diagnosis.

What the season outlook says

NFL Network’s Ian Rapoport and ESPN’s Adam Schefter reported that Hurts was expected to miss the rest of the 2026 season. They also reported an expected recovery period of about three months. Those are attributed expectations, not an Eagles announcement that his season is definitively over.

The team’s public statements and the reporters’ outlook answer different questions. The Eagles’ Oct. 17 notice confirms the injured-reserve placement. The later statement from the team and agent describes the diagnosis and contact restrictions. The likely length of the absence comes from the reporters’ account, as carried by NFL.com.

The team and agent said Hurts’s prognosis was very good and that they expected a full recovery. They also said he could resume contact football activities after coming off blood thinners. No return date has been announced in the reports reviewed here.